bioRxivCell Biology
Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness Versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis
J. M. SanMiguel, E. Eudy, M. A. Loberg, K. A. Young, J. J. Mistry, L. S. Schwartz, T. Stearns, G. A. Challen, J. J. Trowbridge
Abstract
Clonal hematopoiesis resulting from enhanced fitness of mutant hematopoietic stem cells (HSCs) associates with both favorable and unfavorable health outcomes related to the types of mature mutant blood cells produced, but how this lineage output is regulated is unclear. Using a mouse model of a clonal hematopoiesis-associated mutation, DNMT3AR882/+ (Dnmt3aR878H/+), we found that aging-induced TNF signaling promoted the selective advantage of mutant HSCs as well as stimulated mutant B lymphoid cell production. Genetic loss of TNF receptor TNFR1 impaired mutant HSC fitness without altering lineage output, while loss of TNFR2 reduced lymphoid cell production and favored myeloid cell production from mutant HSCs without altering overall fitness. These results support a model where clone size and mature blood lineage production can be independently controlled to harness potential beneficial aspects of clonal hematopoiesis. Statement of SignificanceThrough identification and dissection of TNF signaling as a key driver of murine Dnmt3a-mutant hematopoiesis, we report the discovery that clone size and production of specific mature blood cell types can be independently regulated.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mesenchymal Stromal Cell Senescence Induced by Dnmt3a-Mutant Hematopoietic Cells is a Targetable Mechanism Driving Clonal Hematopoiesis and Initiation of Hematologic Malignancy
Jayna J. Mistry, Kira A. Young, … Jennifer J. Trowbridge·bioRxiv·Mar 28, 2024
- Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging
N. A. Jakobsen, S. Turkalj, … P. Vyas·bioRxiv·Sep 12, 2023
- Delayed Trp53 activation protects Dnmt3a-mutant hematopoietic stem cells from inflammatory attrition.
Ludovica Marando, George Giotopoulos, … Brian J.P. Huntly·bioRxiv·Jan 27, 2025
- DNMT3A-R882 mutations intrinsically drive dysfunctional neutropoiesis from human haematopoietic stem cells
Giovanna Mantica, Aditi Vedi, … Elisa Laurenti·bioRxiv·Oct 8, 2025
- Neutrophil-Derived S100A8/A9 Drives Inflammation that Promotes Dnmt3a -Mutant Hematopoiesis
Jayna J. Mistry, Natalie R Fournier, … Jennifer J. Trowbridge·bioRxiv·Jun 27, 2026
- Retrotransposons Promote Dnmt3a-Mutant Clonal Hematopoiesis Through Aging-Related Stromal Inflammation
Qiongdi Zhang, Wenhuo Hu, … Sisi Zheng·bioRxiv·Jul 2, 2026